TNFSF9 and diffuse large B-cell lymphoma: The role of TNFSF9 deletion in DLBCL pathogenesis remains unclear, but a 19p13.3 deletion involving TNFSF9 was reported to be associated with adverse outcomes in DLBCL [39].